Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03222128 · ClinicalTrials.gov registry record · NA
PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - S3 Intermediate
A NA study of Symptomatic Severe Aortic Stenosis, sponsored by Edwards Lifesciences.
- Completed
- Registry status
- NA
- Development phase
- 1,074
- Enrollment target
- 20
- Study locations
NCT03222128 is a NA study of Symptomatic Severe Aortic Stenosis that has completed, run by Edwards Lifesciences. The registered enrollment target is 1,074 participants. The trial reports 20 study locations across 12 states.
The verdict
NCT03222128, a NA study of Symptomatic Severe Aortic Stenosis, has completed, sponsored by Edwards Lifesciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,074 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this trial is to determine the safety and effectiveness of the Edwards SAPIEN 3 transcatheter heart valve and delivery systems which are intended for use in patients with symptomatic, calcific, and severe aortic stenosis, and those with intermediate risk.
Conditions Studied
Interventions
- DEVICE TAVR
Study Locations (20)
California
- Scripps Green Hospital - La Jolla
- Cedars-Sinai Medical Center - Los Angeles
- Mercy General Hospital - Sacramento
- Stanford University Medical Center - Stanford
Illinois
- Northwestern University - Chicago
- Rush University Medical Center - Chicago
- Northshore - Evanston
- Prairie Education and Research Cooperative - Springfield
Florida
- Morton Plant Hospital - Clearwater
- University of Florida - Gainesville
Indiana
- Indiana University Health-Methodist Hospital - Indianapolis
- St. Vincent Medical Group, Inc./St. Vincent Heart Center of Indiana, LLC - Indianapolis
Colorado
- University of Colorado Hospital - Denver
District of Columbia
- Washington Hospital Center - Washington D.C.
Georgia
- Emory University - Atlanta
Iowa
- The University of Iowa - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,074 participants |
| Start Date | 2014-02-17 |
| Est. Completion | 2024-10-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03222128
The ClinicalTrials.gov registry entry for NCT03222128 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,074 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Edwards Lifesciences, which has 57 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Symptomatic Severe Aortic Stenosis appearing as the primary indexed condition, and to 1 intervention - of which TAVR is the first listed.
NCT03222128 reports 20 study locations spanning 12 distinct geographic areas - top geographies include California, Illinois, Florida.
Frequently Asked Questions
What is clinical trial NCT03222128 about?
NCT03222128 is a clinical study titled "PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - S3 Intermediate". The purpose of this trial is to determine the safety and effectiveness of the Edwards SAPIEN 3 transcatheter heart valve and delivery systems which are intended for use in patients with symptomatic, calcific, and severe aortic stenosis, and those with intermediate risk.
What is the current status of trial NCT03222128?
This trial is currently completed. It is a NA study. The enrollment target is 1,074 participants. The study started on 2014-02-17. Estimated completion is 2024-10-09.
What conditions does trial NCT03222128 study?
This clinical trial studies the following conditions: Symptomatic Severe Aortic Stenosis.
What interventions are being tested in trial NCT03222128?
The interventions under investigation include: TAVR (DEVICE).
Who is sponsoring clinical trial NCT03222128?
This trial is sponsored by Edwards Lifesciences, which has 57 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03222128 being conducted?
This trial has 20 study locations across California, Colorado, District of Columbia, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Symptomatic Severe Aortic Stenosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.